APA (7th ed.) Citation

Ragnoli, B., Morjaria, J., Pignatti, P., Montuschi, P., Barbieri, M., Mondini, L., . . . Malerba, M. (2022). Dupilumab and tezepelumab in severe refractory asthma: New opportunities. SAGE Publishing.

Chicago Style (17th ed.) Citation

Ragnoli, Beatrice, Jaymin Morjaria, Patrizia Pignatti, Paolo Montuschi, Mariangela Barbieri, Lucrezia Mondini, Luca Ruggero, Liliana Trotta, and Mario Malerba. Dupilumab and Tezepelumab in Severe Refractory Asthma: New Opportunities. SAGE Publishing, 2022.

MLA (9th ed.) Citation

Ragnoli, Beatrice, et al. Dupilumab and Tezepelumab in Severe Refractory Asthma: New Opportunities. SAGE Publishing, 2022.